Corcept Therapeutics

NASDAQ: CORT · Real-Time Price · USD
71.72
-0.28 (-0.39%)
At close: Aug 15, 2025, 3:59 PM
71.75
0.03%
After-hours: Aug 15, 2025, 04:54 PM EDT

Corcept Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
127.67M 135.55M 436.62M 335.81M
Short-Term Investments
255.67M 232.67M 365.34M 145.92M
Long-Term Investments
219.83M 57.18M 4.95M 112.28M
Other Long-Term Assets
10.19M 14.79M 17.17M 14.4M
Receivables
53.98M 41.12M 31.06M 27.63M
Inventory
12.41M 7.73M 17.03M 17.95M
Other Current Assets
10.57M 15.7M 30.42M 1.4M
Total Current Assets
471.6M 458.64M 498.71M 381.39M
Property-Plant & Equipment
8.01M 315K 1.14M 514K
Goodwill & Intangibles
n/a n/a n/a -112.28M
Total Long-Term Assets
368.95M 162.88M 84.72M 42.37M
Total Assets
840.55M 621.52M 583.43M 423.76M
Account Payables
15.38M 17.4M 11.98M 6.91M
Deferred Revenue
n/a 18.47M 11.1M 11.17M
Short-Term Debt
n/a n/a 1.14M 526K
Other Current Liabilities
124.38M 29M 42.63M 24.28M
Total Current Liabilities
140.77M 104.5M 81.59M 6.91M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
20.19M 10.31M 9.1M 409K
Total Long-Term Liabilities
20.19M 10.31M 9.1M 41.04M
Total Liabilities
160.96M 114.81M 81.59M 47.95M
Total Debt
6.94M 151K 1.14M 526K
Common Stock
136K 133K 131K 127K
Retained Earnings
543.74M 402.53M 296.39M 194.97M
Comprehensive Income
-217K 609K -869K -227K
Shareholders Equity
679.59M 506.7M 501.84M 375.81M
Total Investments
475.5M 289.85M 370.29M 258.19M